department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

CAPRICOR THERAPEUTICS, INC. ($CAPR) · pharmadog

PUBLIC COMPANY

$CAPRCAPRICOR THERAPEUTICS, INC.

$CAPR

San Diego, CA, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

2

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 11pre_registration

Exosome-Based Vaccine

Coronavirus Disease 2019 (COVID-19)

pre_registration

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

30 open roles at CAPRICOR THERAPEUTICS, INC. →

Where CAPRICOR THERAPEUTICS, INC. is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaRare Disease 29 CNS / Neuroscience 1

departmentQuality 9 Manufacturing / CMC 7 Supply Chain 3 Medical Affairs 2 IT & Engineering 2 Commercial 1

News

no news has mentioned this company yet

identifiers

ticker

$CAPR

SEC CIK

0001133869

country

US

source

sec_tickers

top tags

Cardiology1 Duchenne Muscular Dystrophy1 Infectious Disease1

mentioned in

0news items

entity-linker matched

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 1m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Insider activity

source: SEC Form 4

open-market buys + sells

Apr 2, 26SELLSabar Karimah Es· 7,529 sh @ $32.00−$241K↗
Apr 1, 26SELLSabar Karimah Es· 53,735 sh @ $31.03−$1.67M↗
Mar 31, 26SELLSabar Karimah Es· 61,265 sh @ $30.17−$1.85M↗
Mar 31, 26SELLBergmann Anthony· CHIEF FINANCIAL OFFICER25,000 sh @ $30.13−$753K↗
Mar 31, 26SELLKrasney Karen· EVP, GENERAL COUNSEL25,000 sh @ $30.12−$753K↗

routine RSU / option mechanics (6)

Apr 2, 26option exerciseSabar Karimah Es · 7,529 sh
Apr 2, 26option exerciseSabar Karimah Es · 7,529 sh
Apr 1, 26option exerciseSabar Karimah Es · 53,735 sh
Apr 1, 26option exerciseSabar Karimah Es · 53,735 sh
Mar 31, 26option exerciseSabar Karimah Es · 61,265 sh
Mar 31, 26

option exercise

Krasney Karen · EVP, GENERAL COUNSEL

21,488 sh

Active trials

phase3A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophyactive not recruitingn=106
phase2Open-label Extension of the HOPE-2 Trialactive not recruitingn=13
phase2A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophycompletedn=20
phase2Intravenous Infusion of CAP-1002 in Patients With COVID-19completedn=55
phase2HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)completedn=25
phase2Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)completedn=8
phase2Allogeneic Heart Stem Cells to Achieve Myocardial Regenerationterminatedn=135